Blend Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	84.52	30.96	124.2	213.08	41.27	23.27
Short-Term Investments	43.5	105.96	229.95	334.15	110.63	104.62
Cash & Cash Equivalents	128.03	136.92	354.15	547.23	151.9	127.89
Cash Growth	-58.28%	-61.34%	-35.28%	260.27%	18.77%	-
Receivables	18.18	18.35	22.72	34.08	14.98	2.9
Other Current Assets	13.32	14.57	19.23	31.71	19.27	14.06
Total Current Assets	159.53	169.84	396.1	613.02	186.15	144.85
Property, Plant & Equipment	14.34	12.51	17.41	20.87	17.28	2.96
Long-Term Investments	7.29	7.29	5.36	5.36	5.02	5.2
Goodwill and Intangibles	2.1	2.11	2.13	460.24	1.21	4.14
Other Long-Term Assets	18.5	14.32	11.77	13.01	6.09	4.16
Total Long-Term Assets	42.24	36.23	36.67	499.47	29.6	16.45
Total Assets	201.76	206.07	432.76	1,112	215.75	161.3
Accounts Payable	1.9	2.17	1.26	6.16	3.44	3.14
Deferred Revenue	21.54	8.98	8.7	8.07	13.62	12.4
Other Current Liabilities	19.12	20.42	25.52	45.8	17.97	6.19
Total Current Liabilities	42.56	31.57	35.47	60.03	35.03	21.73
Long-Term Debt	145.25	145.32	227.89	228.45	14	0
Other Long-Term Liabilities	2.06	2.23	5.48	13.42	3.38	4.6
Total Long-Term Liabilities	147.31	147.54	233.37	241.87	17.38	4.6
Total Liabilities	189.87	179.12	268.84	301.9	52.41	26.33
Total Debt	145.25	145.32	227.89	228.45	14	0
Debt Growth	-36.22%	-36.23%	-0.24%	1531.32%	-	-
Retained Earnings	-1,362.3	-1,341.63	-1,162.94	-442.77	-272.85	-198.24
Comprehensive Income	0.35	0.44	-0.71	-0.81	-0.01	0.09
Shareholders' Equity	-35.76	-19.24	123.17	774.64	163.34	134.97
Net Cash / Debt	-17.23	-8.39	126.26	318.78	137.89	127.89
Net Cash / Debt Growth	-	-	-60.39%	131.18%	7.82%	-
Net Cash Per Share	-0.07	-0.03	0.54	2.42	3.50	3.90
Working Capital	116.97	138.26	360.62	552.99	151.12	123.12
Book Value Per Share	-0.14	-0.08	0.53	5.87	4.14	4.12

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).